XML 30 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
 12 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Cash flows from operating activities:    
Net income (loss) $ (7,891,290) $ (21,009,953)
Adjustment to reconcile net income (loss) to net cash:    
Non-cash compensation expense (23,271)  
Non-cash interest expense 491,147  
Non-cash expense for investor relation related services   24,239
Deferred taxes 172,828 4,100,385
Depreciation 996,403 785,066
Write back of liability   (269,124)
Provision for doubtful receivables and bad debts written off   4,644,028
Unrealized foreign exchange (gain)/loss 694,532  
Interest expense (including non-cash)   917,401
Loss on extinguishment of debt   191,804
Impairment loss – goodwill   5,792,849
Impairment loss – Sricon investment   2,184,599
Accrued unrealized share in profits of joint venture (28,463)  
Changes in:    
Accounts receivable 587,118 (6,822)
Inventories 5,557 30,235
Prepaid expenses and other current assets 458,657 1,348,513
Trade payables (856,704) (1,499,804)
Other current liabilities 17,840 (89,898)
Other non-current liabilities (442,685) 91,364
Accrued expenses 2,746,250  
Non-current assets (1,950,281) 130,382
Net cash used in operating activities (5,022,362) (2,634,736)
Cash flow from investing activities:    
Purchase of property and equipment (5,480) (285,441)
Proceeds from sale of property and equipment 48,118 30,705
Proceeds from sale of short term investments 0 0
Proceeds from/ (Investment in) non-current investments (joint ventures etc.) 169,758 (59,235)
Deposits towards acquisitions (net of cash acquired) 2,678,119  
Restricted cash 1,778,063 269,270
Net cash movement relating to de-consolidation of subsidiary 0 0
Net cash provided/(used) in investing activities 4,668,578 (44,701)
Cash flows from financing activities:    
Proceeds from/ (Repayment of) short term borrowings (625,763) (229,068)
Repayment of long term borrowings 0 0
Expenses for issuance of stock   (66,677)
Issuance of equity shares   3,910,575
Repayment of notes payable   (200,000)
Net cash provided/(used) by financing activities (625,763) 3,414,830
Effects of exchange rate changes on cash and cash equivalents (40,789) 4,968
Net increase/(decrease) in cash and cash equivalents (1,020,335) 740,361
Cash and cash equivalent at the beginning of the period 1,583,284 842,923
Cash and cash equivalent at the end of the period $ 562,948 $ 1,583,284